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Introduction 
Idiopathic progressive facial hemiatrophy, or the Parry-
Romberg syndrome, is a very rare entity of unknown 
aetiology. It is seldom described, even in standard medical 
texts. It was first reported in 1825. In its simplest form, it 
involves atrophy of the facial subcutaneous fat and muscles. 
In the more extensive and severe forms, it presents with 
atrophic changes in the skin, muscles and bone of one 
side of the face, and it may be associated with epilepsy, 
encephalitis or trigeminal neuropathy. It is closely related to 
other causes of acquired localised atrophy of the face, like 
linear scleroderma en coup de sabre.
Though classified by some as one of the trophoneuroses 
(a group of diseases with localised dysfunction of the 
autonomic nervous system and trophic changes), others 
believe that it may be a variant of localised scleroderma 
or lupus profundus. The exact nature of this condition 
is currently not fully known. However, it is amenable to 
reconstructive cosmetic surgery in its simplest form, for the 
facial disfigurement it causes.
Here a case is reported in a 21-year-old man with progressive 
wasting of the left facial muscles without skin or bone 
involvement, and no other associated conditions or family 
history. To the best of our knowledge, it is probably the first 
case presented in Nigeria to be reported in literature. 
Case study
The patient was a 21-year-old secondary school leaver, who 
presented with a progressive history of wasting of the left 
side of the face over a one-year period prior to presentation 
at the Consultants’ Outpatient Clinic of the Federal Medical 
Centre, Owo, Nigeria. He claimed to have been in good 
health, with no associated changes in skin colour or texture 
of the face, and denied any pain, photosensitivity, or 
alteration in sweating pattern.
There was no known family history of a similar condition, 
or any previous medications or epilepsy. No abnormality of 
mastication was reported. He claimed to have presented 
in hospital because of the facial disfigurement and the 
attendant cosmetic effect.
Examination revealed a young man who was not ill-looking, 
except for the obvious wasting of the left facial muscles (See 
Figures 1 and 2.) There were no other stigmata of chronic 
illness, the skin was normal, and the  cardiovascular and 
respiratory systems and abdomen were unremarkable. The 
nervous system was essentially normal, and remarkably, 
higher mental functions, cranial nerves and sensation were 
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all intact. Obvious wasting of the left masseter, temporalis 
and buccinator muscles was evident. There was no sign 
of fasciculations, or clinical evidence of denervation or 
tenderness. Other muscle groups and joints in the body 
were essentially normal. The results of a complete blood 
count and the erythrocyte sedimentation rate were normal. 
Human immunodeficiency virus serology was negative. 
Results of available autoimmune tests for antinuclear 
factor, anti-double-stranded DNA and creatine kinase levels 
were within normal limits. Lipid panel was also normal. An 
impression of idiopathic acquired left facial hemiatrophy 
was made. The patient was referred for a consultation in the 
plastic surgical unit.
Discussion
Idiopathic acquired progressive hemifacial atrophy, Parry-
Romberg syndrome, is a rare entity. Although it was first 
described in 1825, it remains incompletely understood.1 
This is evident in the nosology and possible aetiology 
of the condition. While some classify it as one of the 
trophoneuroses (a group of diseases with autonomic 
dysfunction and trophic changes), others have classified it 
as a variant of localised scleroderma, like scleroderma en 
coup de sabre (“like the stroke of a sword”) on the upper 
face and lateral scalp, and others still see it as a variant 
of lupus profundus with panniculitis involving the face – 
all underscoring the poor understanding of the entity.2,3 
However, it is hypothesised that a disturbance of cerebral fat 
metabolism may be the primary cause. This can be a result 
of trophic malformation of the cervical sympathetic nervous 
system, possibly triggered by pathogenetic mechanisms 
(such as trauma), viral infection, autoimmunity, heredity or 
endocrine disturbance.3
In its simplest form, it involves progressive unilateral wasting 
of the muscles of the face, as in the case described above, 
without any changes in the skin or bone or manifestations 
of central nervous system abnormality. However, in the 
more severe forms, it might be associated with unilateral 
structural changes in the brain, with atrophy and epilepsy. 
Localised encephalitis of the Rasmussen’s type has been 
described.4-6 It also has been associated with status 
migrainosus, an alien hand syndrome from contralateral 
thalamic degeneration, as well as an infection with Borriela 
burgdoferi (the aetiological agent of Lyme disease) – all 
underscoring the complex nature of this clinical entity.7-10 
The clinical depression from the attendant cosmetic loss 
as a result of the facial disfigurement is one of the major 
reasons the patient presents in hospital.11 It may start in 
childhood, or first present in adulthood.
Figure 1. Front view of the face Figure 2. Left side view of the face
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It is important to differentiate this condition from others that 
may present with facial disfigurement, so that treatment 
is not misapplied. Such other conditions include linear 
scleroderma en coup de sabre, with which it is easily 
confused. Several sources suggest that they are one and 
the same entity and that they may be different presentations 
of the same illness.12 The characteristic skin changes, a 
tendency of linear scleroderma to involve the upper face 
and scalp more often than Parry-Romberg syndrome, 
which has a predilection for the lower face and cheeks, and 
the autoimmune test results seen in scleroderma may be 
important differentiating factors.4,12,13 
The next condition is acquired localised lipodystrophy, 
in which there is atrophy with or without hypertrophy of 
subcutaneous fat. This tends to be more widely distributed 
beyond the face, even in the idiopathic form (Barraquer-
Simmons syndrome), where lipoatrophy may start from 
the face before involving other parts of the body. Its 
association with metabolic disorders like hyperglycaemia, 
dyslipidaemia, positive antinuclear factor and anti-double-
stranded DNA in the majority of the patients may be helpful 
in distinguishing this condition.14 Localised lipoatrophy may 
also occur following prolonged, highly active antiretroviral 
therapy, particularly with the protease inhibitors. But this 
lipoatrophy usually tends to be more widely distributed.14 
There are currently no clear-cut criteria for the diagnosis of 
Parry-Romberg syndrome, and hence it remains a diagnosis 
of exclusion.
Treatment options for Parry-Romberg syndrome include 
cosmetic surgical reconstruction and possibly the use of 
immunosuppressants. The latter have been used in some 
situations with good results. An interdisciplinary approach 
is usually required.15-17
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